Posts

KOL Insight – Psoriatic Arthritis (Recent Trends, June 2026)

on

GHO Capital and CBC Group to merge into world’s largest dedicated healthcare investor

on

Recent developments in transforming oversight and risk management in pharma R&D

on

Astellas Pharma Top Management Personnel Changes (October 2025)

on

After Missing Kezar Buyout in 2024, Kevin Tang Returns as CEO of Aurinia with $50M Offer

on

FDA Clears BrainSpace Intellidrop: Automated Neuro Device Tackling ICU Nursing Shortages and Advancing Physical AI

on

Coloplast announces changes to Executive Leadership Team

on

Bayer's Pharma Division Grows as Restructuring Drives Major Changes

on

Weight-loss drug stocks drop after Trump pledges major price cuts

on

X4 Pharma Halves Workforce in Second Round of 2025 Layoffs

on

Personalizing Metabolic Care with Digital Twins: Recent Developments

on

Trump Administration Unveils Health Data Sharing Scheme Backed by Apple, Amazon, and Others

on

Lark Health Launches LarkVantage: AI-Powered Platform to Manage GLP-1 Costs

on

Eli Lilly Strikes $650M Deal with Juvena to Develop Muscle-Boosting Drugs

on

Trump Administration Cancels Major Federal Funding for Moderna's Bird Flu Vaccine

on

Chronic care startup Omada Health files to go public

on

Leaked HHS budget signals $40B in cuts, assumes ACA subsidies expire

on

Harvard Faces $2.2 Billion Federal Funding Freeze After Defying Trump Administration Demands

on

Appeals Court Blocks Reinstatement of Fired Federal Probationary Workers, Affecting 20 Agencies

on

Federal Judge Blocks NIH Grant Caps as HHS Appeals Ruling

on